Category: Federal Forum Posters
Purpose: Since their approval, long-acting glycopeptides given as a one-time dose for skin and soft tissue infections offer a novel treatment approach compared to traditional courses of oral antibiotics. The purpose of this medication use evaluation will help determine the proportion of patients appropriately treated for skin and soft tissue infection with oral antibiotics and if they would have benefitted from a one-time dose of a long-acting glycopeptide during their emergency room visit.
Methods: A retrospective chart review of the electronic medical record will be conducted for patients between the ages of 18 and 85 discharged from the emergency room with a diagnosis of skin and soft tissue infection between July 1st, 2017 and June 30th, 2018. Patients will be excluded if they were diagnosed with any of the following conditions: sepsis, bacteremia, catheter-site or device-related infections, osteomyelitis, necrotizing fasciitis, endocarditis, or chronic infections (i.e. diabetic foot infections, decubitus ulcers, vascular ulcers, burns). The following information will be collected and analyzed: patient demographics, comorbidities, infection severity, organisms cultured, and antibiotics prescribed.
Results: Not applicable
Conclusion: Not applicable
Michael Bosco– Pharmacy Resident, James J. Peters VA Medical Center, Bronx, NY